Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Oriental Fortune Capital is a venture capital firm founded in 2006. It manages multiple funds, including those focused on TMT, Green Technology, and Medical & Healthcare Service. The firm invests across various stages from early to pre-IPO in sectors such as TMT, healthcare, biotech, and advanced manufacturing, with an AUM of US$4.8 billion as of 2024.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Oriental Fortune Capital.